Get the Stockscreener App
0.000001
0.00%
0.00
Biolife Sciences Inc Stock (BLFE) Forecast
The Biolife Sciences Inc (BLFE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.2372, representing a +23.72M% increase from the current price of $0.000001. The highest analyst price target is $0.2528, and the lowest is $0.2216.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BLFE Price Target
Average 0.25
(+25.00M% Upside)
Long-term BLFE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Biolife Sciences Inc financial reports and earnings history, Biolife Sciences Inc (BLFE) stock could reach $0.7423 by 2030, $2.4371 by 2040 and $1.2429 by 2050. See the projected annual prices until 2050 of the Biolife Sciences Inc stock below:
- Biolife Sciences Inc (BLFE) is expected to reach an average price of $1.2887 in 2035, with a high prediction of $1.5338 and a low estimate of $1.2957. This indicates an $128.87M% rise from the last recorded price of $0.000001.
- Biolife Sciences Inc (BLFE) stock is projected to chart a bullish course in 2040, with an average price target of $2.0973, representing an $209.73M% surge from its current level. The forecast ranges from a conservative $2.1106 to a sky-high $2.4371.
- Our analysts predict Biolife Sciences Inc (BLFE) to jump 306.92M% by 2045, soaring from $0.5298 to an average price of $3.0692, potentially reaching $3.2597. While $0.5298 is the low estimate, the potential upside is significant.
- Biolife Sciences Inc (BLFE) stock is expected to climb by 2050, reaching an average of $0.9479, a $94.79M% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.2429 and $0.6528, respectively, highlighting the market's uncertainty.
Biolife Sciences Inc Stock (BLFE) Year by Year Forecast
Biolife Sciences Inc Stock (BLFE) Price Forecast for 2025
Biolife Sciences Inc Stock (BLFE) is expected to reach an average price of $0.2111 in 2025, with a high prediction of $0.3731 and a low estimate of $0.0492. This indicates an +21.11M% rise from the last recorded price of $0.000001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $0.2213 | $0.2216 | $0.2528 | +22.13M% |
| July, 2025 | $0.1528 | $0.1587 | $0.2002 | +15.28M% |
| August, 2025 | $0.1031 | $0.1031 | $0.1278 | +10.31M% |
| September, 2025 | $0.3901 | $0.0604 | $0.3731 | +39.01M% |
| October, 2025 | $0.3456 | $0.3588 | $0.3685 | +34.56M% |
| November, 2025 | $0.2978 | $0.3036 | $0.321 | +29.78M% |
| December, 2025 | $0.207 | $0.2222 | $0.2724 | +20.70M% |
Biolife Sciences Inc Stock (BLFE) Price Forecast for 2026
The predicted value for Biolife Sciences Inc (BLFE) in 2026 is set at an average of $0.2889. Estimates vary from a peak of $0.5062 to a trough of $0.0715, indicating an +28.89M% surge from the present price of $0.000001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.1575 | $0.1604 | $0.1893 | +15.75M% |
| February, 2026 | $0.0865 | $0.0876 | $0.1379 | +8.65M% |
| March, 2026 | $0.4326 | $0.0715 | $0.4397 | +43.26M% |
| April, 2026 | $0.3763 | $0.3818 | $0.4123 | +37.63M% |
| May, 2026 | $0.2892 | $0.3062 | $0.3507 | +28.92M% |
| June, 2026 | $0.2104 | $0.2163 | $0.2729 | +21.04M% |
| July, 2026 | $0.1406 | $0.1406 | $0.1804 | +14.06M% |
| August, 2026 | $0.5232 | $0.0827 | $0.5062 | +52.32M% |
| September, 2026 | $0.4586 | $0.4718 | $0.4967 | +45.86M% |
| October, 2026 | $0.3907 | $0.3965 | $0.429 | +39.07M% |
| November, 2026 | $0.2747 | $0.2898 | $0.3602 | +27.47M% |
| December, 2026 | $0.205 | $0.2079 | $0.2519 | +20.50M% |
Biolife Sciences Inc Stock (BLFE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Biolife Sciences Inc (BLFE) is $0.3666, with a high forecast of $0.6394 and a low forecast of $0.0939. This indicates an +36.66M% increase from the last price of $0.000001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1139 | $0.115 | $0.1804 | +11.39M% |
| February, 2027 | $0.5707 | $0.0939 | $0.5728 | +57.07M% |
| March, 2027 | $0.4792 | $0.4847 | $0.5324 | +47.92M% |
| April, 2027 | $0.372 | $0.389 | $0.4486 | +37.20M% |
| May, 2027 | $0.2681 | $0.274 | $0.3468 | +26.81M% |
| June, 2027 | $0.178 | $0.1781 | $0.233 | +17.80M% |
| July, 2027 | $0.6811 | $0.1051 | $0.6339 | +68.11M% |
| August, 2027 | $0.5716 | $0.5848 | $0.6394 | +57.16M% |
| September, 2027 | $0.4836 | $0.4894 | $0.537 | +48.36M% |
| October, 2027 | $0.3827 | $0.3938 | $0.4481 | +38.27M% |
| November, 2027 | $0.2526 | $0.2555 | $0.3333 | +25.26M% |
| December, 2027 | $0.1413 | $0.1424 | $0.2229 | +14.13M% |
Biolife Sciences Inc Stock (BLFE) Price Forecast for 2028
In 2028, Biolife Sciences Inc (BLFE) is projected to reach an average price of $0.4787, with a high projection of $0.8412 and a low estimate of $0.1163. This indicates an +47.87M% rise from the last price of $0.000001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6787 | $0.1163 | $0.706 | +67.87M% |
| February, 2028 | $0.5822 | $0.5877 | $0.6484 | +58.22M% |
| March, 2028 | $0.4548 | $0.4718 | $0.5465 | +45.48M% |
| April, 2028 | $0.3492 | $0.3529 | $0.4246 | +34.92M% |
| May, 2028 | $0.2155 | $0.2155 | $0.3169 | +21.55M% |
| June, 2028 | $0.8193 | $0.1274 | $0.7721 | +81.93M% |
| July, 2028 | $0.6846 | $0.6979 | $0.7726 | +68.46M% |
| August, 2028 | $0.5765 | $0.5823 | $0.645 | +57.65M% |
| September, 2028 | $0.4554 | $0.4665 | $0.5359 | +45.54M% |
| October, 2028 | $0.3001 | $0.303 | $0.401 | +30.01M% |
| November, 2028 | $0.1686 | $0.1697 | $0.2654 | +16.86M% |
| December, 2028 | $0.827 | $0.1386 | $0.8412 | +82.70M% |
Biolife Sciences Inc Stock (BLFE) Price Forecast for 2029
The 2029 price forecast for Biolife Sciences Inc Stock (BLFE) is $0.5646 on average, with a high prediction of $0.9794 and a low estimate of $0.1498. This represents an +56.46M% increase from the previous price of $0.000001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6851 | $0.6906 | $0.7786 | +68.51M% |
| February, 2029 | $0.5376 | $0.5546 | $0.6444 | +53.76M% |
| March, 2029 | $0.4119 | $0.4155 | $0.5023 | +41.19M% |
| April, 2029 | $0.253 | $0.253 | $0.3745 | +25.30M% |
| May, 2029 | $0.9575 | $0.1498 | $0.9103 | +95.75M% |
| June, 2029 | $0.8429 | $0.8454 | $0.9057 | +84.29M% |
| July, 2029 | $0.6693 | $0.6751 | $0.7906 | +66.93M% |
| August, 2029 | $0.5281 | $0.5392 | $0.6237 | +52.81M% |
| September, 2029 | $0.3732 | $0.3768 | $0.4686 | +37.32M% |
| October, 2029 | $0.196 | $0.1971 | $0.3315 | +19.60M% |
| November, 2029 | $0.9551 | $0.161 | $0.9794 | +95.51M% |
| December, 2029 | $0.788 | $0.7935 | $0.9017 | +78.80M% |
Biolife Sciences Inc Stock (BLFE) Price Forecast for 2030
Biolife Sciences Inc Stock (BLFE) is expected to reach an average price of $0.6449 in 2030, with a high forecast of $1.1176 and a low forecast of $0.1721. This signifies an +64.49M% surge from the last price of $0.000001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.6204 | $0.6374 | $0.7423 | +62.04M% |
| February, 2030 | $0.4745 | $0.4782 | $0.5801 | +47.45M% |
| March, 2030 | $0.33 | $0.3321 | $0.4321 | +33.00M% |
| April, 2030 | $1.0957 | $0.1721 | $1.0485 | +109.57M% |
| May, 2030 | $0.961 | $0.9635 | $1.0389 | +96.10M% |
| June, 2030 | $0.7992 | $0.8062 | $0.9036 | +79.92M% |
| July, 2030 | $0.6008 | $0.6119 | $0.7563 | +60.08M% |
| August, 2030 | $0.4258 | $0.4294 | $0.5363 | +42.58M% |
| September, 2030 | $0.2234 | $0.2245 | $0.3791 | +22.34M% |
| October, 2030 | $1.0832 | $0.1833 | $1.1176 | +108.32M% |
| November, 2030 | $0.9216 | $0.9265 | $1.0248 | +92.16M% |
| December, 2030 | $0.7032 | $0.7202 | $0.8716 | +70.32M% |
5.71%
0.34%
Cap:
|
Volume (24h):